期刊
JOURNAL OF NEUROINFLAMMATION
卷 13, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12974-016-0682-8
关键词
Type-1 cannabinoid receptor; Striatum; Interleukin-1 beta; Anxiety; Experimental autoimmune encephalomyelitis
资金
- Italian National Ministero dell'Universita [2010BN3MXM_007]
- German Research Foundation DFG [FOR926]
- Italian National Ministero della Salute (Progetto Giovani Ricercatori) [GR-2011-02351422, GR-2011-02347036]
- Fondazione Italiana Sclerosi Multipla (FISM) fellowship
Background: Mood disorders, including anxiety and depression, are frequently diagnosed in multiple sclerosis (MS) patients, even independently of the disabling symptoms associated with the disease. Anatomical, biochemical, and pharmacological evidence indicates that type-1 cannabinoid receptor (CB1R) is implicated in the control of emotional behavior and is modulated during inflammatory neurodegenerative diseases such as MS and experimental autoimmune encephalomyelitis (EAE). Methods: We investigated whether CB1R could exert a role in anxiety-like behavior in mice with EAE. We performed behavioral, pharmacological, and electrophysiological experiments to explore the link between central inflammation, mood, and CB1R function in EAE. Results: We observed that EAE-induced anxiety was associated with the downregulation of CB1R-mediated control of striatal GABA synaptic transmission and was exacerbated in mice lacking CB1R (CB1R-KO mice). Central blockade of interleukin-1 beta (IL-1 beta) reversed the anxiety-like phenotype of EAE mice, an effect associated with the concomitant rescue of dopamine (DA)-regulated spontaneous behavior, and DA-CB1R neurotransmission, leading to the rescue of striatal CB1R sensitivity. Conclusions: Overall, results of the present investigation indicate that synaptic dysfunction linked to CB1R is involved in EAE-related anxiety and motivation-based behavior and contribute to clarify the complex neurobiological mechanisms underlying mood disorders associated to MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据